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Abstract
Background: The etiology of most premature ovarian failure (POF) cases is usually elusive. Although genetic causes clearly
exist and a likely susceptible region of 8q22.3 has been discovered, no predominant explanation exists for POF. More
recently, evidences have indicated that mutations in NR5A1 gene could be causative for POF. We therefore screened for
mutations in the NR5A1 gene in a large cohort of Chinese women with non-syndromic POF.
Methods: Mutation screening of NR5A1 gene was performed in 400 Han Chinese women with well-defined 46,XX idiopathic
non-syndromic POF and 400 controls. Subsequently, functional characterization of the novel mutation identified was
evaluated in vitro.
Results: A novel heterozygous missense mutation [c.13T.G (p.Tyr5Asp)] in NR5A1 was identified in 1 of 384 patients
(0.26%). This mutation impaired transcriptional activation on Amh, Inhibin-a, Cyp11a1 and Cyp19a1 gene, as shown by
transactivation assays. However, no dominant negative effect was observed, nor was there impact on protein expression
and nuclear localization.
Conclusions: This novel mutation p.Tyr5Asp, in a novel non-domain region, is presumed to result in haploinsufficiency.
Irrespectively, perturbation in NR5A1 is not a common explanation for POF in Chinese.
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Introduction
Premature ovarian failure (POF), also termed primary ovarian
insufficiency (POI), refers to cessation of normal ovarian function
before the age of 40 years. Approximately 1% of the population
has POF prior to age 40 and only 0.1% or less before age 30 [1,2].
The etiology of POF is highly heterogeneous. Chromosomal
abnormalities account for 12% of cases [3], and the familial
aggregation often associated with POF indicates a genetic
contribution. Causative mutations in several genes (e.g., NOBOX,
FIGLA, BMP15 and GDF9) have been identified in non-syndromic
POF [4–8], but none of these genes are perturbed in more than a
small minority of POF cases, in a given ethnic group. More
recently, our genome-wide association study (GWAS) of POF
discovered a significantly susceptible region of 8q22.3; however, it
was concluded as an important yet undefined long distance
regulatory region affecting oogenesis [9]. Therefore, the underly-
ing explanation for POF remains largely unknown (idiopathic).
Nuclear receptor subfamily 5, group A, member 1 (NR5A1,
MIM#184757), at human chromosome 9q33, encodes steroido-
genic factor 1 (SF1), a nuclear receptor involved in adrenal and
gonadal development, steroidogenesis, and reproduction [10]. SF1
serves as a master transcriptional regulator of multiple genes,
including STAR, CYP11A1, CYP19A1, AMH, INHA, and LHB [11–
15]. Human SF1 protein is mainly expressed in ovarian somatic
cells of growing follicles and corpus lutea [16]. Granulosa cell-
specific Nr5a1 knockout mice exhibit infertility, hypoplastic ovaries
with decreased follicles and absence of corpora lutea [17]. These
findings indicate a critical role of NR5A1 in ovarian development
and function.
In humans, NR5A1 mutations are associated with a wide range
of phenotypes. Heterozygous, or rarely homozygous, variants were
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described in 46,XY disorders of sex development (DSD), with
(rare) or without adrenal insufficiency, and milder phenotypes–
hypospadias, cryptorchidism, anorchidia, and male infertility [18].
A pathogenic role of NR5A1 in 46,XX POF has also been
observed. Lourenco et al. [19] reported 19 different mutations in 4
families in which affected members had 46,XY DSD or 46,XX
POF, and 2 out of 25 (8.0%) sporadic POF cases. In contrast,
subsequent cohort studies demonstrated only a minor contribution
of NR5A1 to POF in several different populations [20–23]. Janse
et al. found 1.4% in New Zealander (mutation carriers from
Asian, Caucasian and Mediterranean); Lakhal et al. found no
mutations in Tunisian but Philibert et al. found 3.8% in Tunisian.
And more recently Voican et al. reported the mutation rate to be
1.6% in French.
Given these discrepant results, we screened the NR5A1 gene in a
large cohort of Chinese women with POF. Our cohort is the
largest collected in any ethnic group and distinct in being
exclusively Han Chinese. We found one novel heterozygous
missense mutation, which was shown to impact functional
significance with impaired transactivation activity.
Methods
Patients
A total of 400 unrelated Han Chinese women with POF were
recruited from Center for Reproductive Medicine, Shandong
Provincial Hospital Affiliated to Shandong University between
April 2003 and June 2012. Inclusion criteria included primary
amenorrhea (PA) or secondary amenorrhea (SA) for at least 6
months prior to the age of 40 years and two measures of serum
FSH.40 IU/L obtained at least 1 month apart. In this cohort, 35
presented with PA and 365 with SA. A positive family history was
considered if another first- or second-degree female family
member had POF or early menopause (menopause before 45
years old). Patients with karyotypic abnormalities, previous
chemo/radio-therapy, ovarian surgery or autoimmune diseases
known to induce POF were excluded. Women with accompanying
somatic anomalies were sought and excluded, particularly any
reported as associated with syndromic POF (e.g., blepharophi-
mosis-ptosis-epicanthus inversus syndrome, neurosensory deafness
and cerebellar ataxia). Four hundred Han Chinese females with
regular menses and normal hormone level were enrolled as
controls.
Ethics Statement
The study was approved by the Institutional Review Board of
Reproductive Medicine of Shandong University. Written in-
formed consent was obtained from each subject.
Mutation Screening of NR5A1 Gene
Genomic DNA was extracted from peripheral blood according
to standard protocols. The entire coding sequence (exon 2–7) and
intron-exon boundaries of NR5A1 gene (NM_004959.4) were PCR
amplified and directly sequenced (ABI 37306l DNA Analyzer,
Applied Biosystems, Foster City, CA). Novel variants identified
were confirmed by bidirectional sequencing from another two
independent PCR products. Nomenclature of variants identified
was established according to Human Genome Variation Society
(HGVS, www.hgvs.org/mutnomen). Primers and PCR conditions
are available upon request.
Plasmids Construction
SF1 expression vector containing p.Y5D mutation was gener-
ated by site-directed mutagenesis (QuikChange Lightning Site-
Directed Mutagenesis Kit; Stratagene, LaJolla, CA) with wild-type
(WT) mouse Sf1 expression vector as a template (a generous gift
from Prof. Jameson). The luciferase reporter vectors containing
SF1-responsive minimal promoters of murine Amh, murine
Inhibin-a, murine Cyp11a1, and rat Cyp19a1 in pGL3-basic
(Promega, Madison, WI, USA) were constructed. For expression
and cellular localization, mouse Nr5a1 cDNA was amplified and
cloned in-frame into pEGFP-C3 expression vector (Clontech,
Mountain View, CA), resulting in a fusion protein with a GFP tag
at its N-terminus (pEGFP-C3-Sf1). The p.Y5D mutation was
introduced as described above. All constructs were validated by
sequencing. Primers used are detailed in Table S1.
Transactivation Activity Assays
Transactivation activity assays were performed in 48-well plates
using Lipofectamine TM 2000 reagent (Invitrogen, Carlsbad, CA)
and a Dual-LuciferaseH reporter assay system (Promega, Madison,
WI, USA). Human embryonic kidney HEK293T cells were
transiently co-transfected by empty (Mock), wild-type (WT), or
mutant (MT) Sf1 expression vectors with reporter constructs
described above. To further assess the possible dominant negative
effect, the WT vector with either empty vector or the mutant (1:1)
was transfected with each reporter. In addition, increasing mutant
vectors (0, 10, 20, 30, 40 ng) in the absence or presence of constant
WT (10 ng) and Amh-pGL3 reporter (540 ng) were co-transfect-
ed. Total transfected plasmids were adjusted with empty vectors.
Renilla reporter pRL-TK (Promega) was used as an internal
control. Cells were lysed 24 hours later, and luciferase activity was
measured with a luminometer reader (Enspire, PerkinElmer).
Results were normalized against Renilla luciferase activity.
Expression and Nuclear Localization
HEK293T cells were transfected either with empty vector
(Mock), WT or with mutant pEGFP-C3-Sf1 expression vector.
Twenty-four hours after transfection, nuclear counterstaining was
performed with Hoechst 33342 (Beyotime Institute of Biotechnol-
ogy, Jiangsu, China), and then visualized under a fluorescence
microscope (Olympus, Tokyo, Japan).
Statistics
Results in transactivation activity assays were expressed as
percentage of WT activity (100%) and represent the Mean6S.D.
of 3 independent experiments, each performed in triplicate.
Statistical significance was examined using Student’s t-test. Chi-
square test was used for comparison of allele frequencies. A P value
,0.05 was considered statistically significant.
Results
A Novel Missense Mutation Identified within Gene NR5A1
The clinical characteristics of the 400 patients studied are
summarized in Table 1. Direct sequencing of NR5A1 gene was
successful in 384 POF patients. A novel heterozygous missense
mutation c.13T.G (p.Tyr5Asp, p.Y5D) in exon 2 was identified
in one individual. This variant was absent in dbSNP database or
400 Chinese control women. The mutated tyrosine, located seven
residues upstream of the first zinc finger DNA-binding domain
(DBD), was highly conserved among SF1 orthologs (Fig. 1).
The single p.Y5D carrier developed spontaneous menarche at
the age of 19, but experienced irregular menses and subsequent
secondary amenorrhea 1 year later. Transvaginal ultrasonography
showed hypoplastic uterus and non-detectable ovaries. FSH was
significantly elevated (78.3 IU/L), while estradiol was undetect-
able. No other family member had POF or a form of 46,XY DSD.
NR5A1 Mutations in POF
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Two known single nucleotide polymorphisms (SNPs), rs1110061
and rs2297605, were also identified. However, the allele frequen-
cies of these SNPs in our POF cohort were not statistically
different from those in the Asian population (P.0.05) (Table S2).
Impaired Transactivation Activity of the p.Y5D Mutant
Transactivation activity assay showed that the p.Y5D mutation
impaired the transactivation activity on different SF1 responsive
promoter reporters, including Amh, Inhibin-a, Cyp11a1 and
Cyp19a1 (all P,0.01) (Fig. 2A, B, C, D). Because of the
heterozygous status of the patient, the dominant negative effect
of the mutant over WT protein was assessed. Co-transfection of
mutant with WT did not interfere with the transactivation of WT
protein either when transfected in a 1:1 ratio (Fig. 2A, B, C, D), or
when increasing mutants transfected with a fixed WT even in ratio
5:1(Amh only) (Fig. 2E).
No Impact of the p.Y5D Mutation on Protein Expression
and Nuclear Localization
To assess the impact of the p.Y5D mutation on protein
expression and nuclear localization, we generated GFP-tagged Sf1
WT and mutant expression vectors and transfected them into
HEK293T cells. The WT showed exclusively strong nuclear
localization with relative nucleolar exclusion. A similar pattern was
seen for the mutant (Fig. 3).
Discussion
In our large cohort of Chinese patients known to have well-
defined 46,XX non-syndromic POF, a novel heterozygous
missense mutation was identified (1/384, 0.26%). The c.13T.G
transition located in exon 2, outside any classic domains of SF1,
resulted in a p.Tyr5Asp mutation. The highly conserved tyrosine
residue was located adjacent to the first zinc finger of DBD, a
region that contributed to specific recognition and interaction with
promoter responsive elements in target genes. In vitro transactiva-
tion assays using Amh, Inhibin-a, Cyp11a1 and Cyp19a1
promoters showed impaired transactivation activity of the p.Y5D
mutant, and thus confirmed its deleterious effect. However, a
dominant negative effect was not observed (Fig. 2), consistent with
previous reports [22,24,25].
The two SNP, rs1110061 and rs2297605, detected in our study
had drawn attention of others. Rs1110061 (Gly146Ala) was
reported to be associated with POF in recent cohorts of Tunisian
women [21,22]. Nevertheless, previous functional assays showed
inconsistent results, that is, Gly146Ala resulted in either a decrease
of 20–35% or no impact on the transactivation activity on target
gene promoters [22,25,26]. Still, given that no significant
difference existed in allele frequency between our POF cohort
Figure 1. Mutations in NR5A1 gene associated with POF. (A). Schematic presentation of the distribution of NR5A1 mutations associated with
POF. DBD: DNA-binding domain, LBD: ligand binding domain, AF2: activation function domain 2. (B). Sequence alignment of SF1 among orthologs
with tyrosine residue highlighted.
doi:10.1371/journal.pone.0074759.g001
Table 1. Clinical characteristics of 400 Chinese women with
POF.
Characteristics Mean±S.D./N (%)
Age at diagnosis (yr) 29.8264.95
Age at menarche (yr)a 14.8562.20
Age of amenorrhea (yr)a 24.3965.86
FSH (IU/L) 76.09629.82
E2 (pmol/L) 25.38642.42
Family history 41(10.3%)
Parental consanguinity 4(1.0%)
aRefer to patients with secondary amenorrhea.
doi:10.1371/journal.pone.0074759.t001
NR5A1 Mutations in POF
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and the general Asian population, we considered rs1110061 to be
only a polymorphism not conferring susceptibility to POF.
POF is genetically heterogeneous probably attributed to the
complex genetic networks modulating human folliculogenesis and
oogenesis. Ovarian phenotypes of Nr5a1 null mice made it an
excellent candidate gene for POF in human. NR5A1/SF1 regulates
the transcription of CYP11A1, CYP19A1, AMH and INH-A genes
involved in steroidogenesis, ovarian development and function.
Dysregulation of any protein encoded by these genes could lead to
ovarian dysfunction. Disruption of CYP11A1 (P450 Side Chain
Cleavage, P450scc) or CYP19A1 (Aromatase) could contribute to
steroid hormones deficiency, estrogen in particular, and subse-
quent abnormal folliculogenesis. Firm evidence indicated an
inhibitory role of AMH in initiation of primordial follicle growth
and FSH responsiveness of small growing follicles [27,28]. As an
important negative regulator of pituitary FSH and paracrine factor
in folliculogenesis, INHIBIN-A is also a downstream target of
NR5A1 [29]. It is plausible that a decline in AMH and inhibin
levels would result in increased recruitment of primordial follicles,
raised FSH or FSH responsiveness of small growing follicles,
increased FSH-dependent cyclic recruitment, and hence, prema-
ture exhaustion of ovarian reserve occurred ultimately [27,29].
However, we cannot exclude the possibility that other regulative
pathways, even other genes, and/or environmental factors might
participate in ovarian pathogenesis.
There have been five POF cohorts of different ethnicities in
which NR5A1 mutations were sought (Table 2). As discussed, the
first identified two causative mutations among 25 sporadic POF
cases (8.0%) [19]. In a large Dutch cohort of 356 POF cases, Janse
et al. [20] later found five non-conservative mutations (1.4%) but
nonetheless concluded that NR5A1 made only a minor contribu-
tion to the pathogenesis for POF. Two Tunisian population were
also studied, one finding no novel perturbations in 55 cases, the
other finding 1 out of 26 cases (3.8%) [21,22]. More recently,
Voican et al. [23] reported three novel missense mutations in 180
French cases (1.6%). The present study revealed a much lower
frequency of NR5A1 mutations in Chinese (0.26%). Discrepant
incidence might indicate differences in predisposing regulating
pathways that lead to POF in ethnically diverse populations. In
fact, similar inconsistency has been observed in other candidate
genes for POF, extremely in FSHR, a frequent explanation of
POF in Finland but rare elsewhere [30].
To date, 18 distinct variants have been reported in all patients
with familial and sporadic POF (Table 2, 3, and Fig. 1) [19–
25,31,32]. Mutations could be de novo or familial. All reported
mutations were heterozygous, except p.Asp293Asn homozygosity
in two Brazilian sibs [19]. Most mutations fell within the hinge
region and ligand binding domain (LBD). Two were located
outside any classic domains; these being a start codon mutation
(p.Met1Ile) detected by Lourenco et al. [19] and the p.Tyr5Asp
mutation in the present study. Both mutations affected highly-
conserved residues. These findings underscore the likelihood of
regulatory effects involving the non-domain region on gene
function. Several variants resulted in impaired transcriptional
activation, but without dominant negative effects. This suggests
that haploinsufficiency alone may be sufficient to cause POF. Of
note, phenotypic variability was remarkable between heterozy-
gotes. Different individuals, even within the same family, having
the same variant, presented with either premature ovarian failure,
early menopause, diminished ovarian reserve (DOR), or normal
ovarian function [31,32]. In familial cases with 46,XY DSD and
Figure 2. Transactivation activity assay. Co-transfection of empty
(Mock), wild-type (WT), or mutant (MT) Sf1 expression vectors and a
Amh (A), Inhibin-a (B), Cyp11a1 (C) or Cyp19a1 (D) promoter reporter
were performed in HEK293T cells. Results are expressed as a percentage
of WT activity (RLU WT%). The potential dominant negative effect of the
p.Y5D mutant was assessed by co-transfecting WT expression vector
with empty or MT vector (1:1) (A, B, C, D) and increasing MT (0, 10, 20,
30, 40 ng) with 10 ng empty (2) or 10 ng WT (+) vector (Amh only) (E)
in HEK293T cells. ** P,0.01, *** P,0.001. RLU, relative light units.
doi:10.1371/journal.pone.0074759.g002
Figure 3. Expression and nuclear localization of p.Y5D mutant.
HEK293T cells were transiently transfected with empty vector (Mock),
wild-type (WT) or mutant (MT) pEGFP-C3-Sf1 expression vector. The
nuclei were counterstained with Hoechst33342 (blue). Scale bar-
s = 10 um.
doi:10.1371/journal.pone.0074759.g003
NR5A1 Mutations in POF
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46,XX POF, a heterozygous NR5A1 mutation could be inherited
from a 46,XX mother either with POF or apparently normal
ovarian function, to the 46,XY DSD offspring in a sex-limited
dominant manner, which was kind of similar to X-linked
inheritance [18,19,31,32] (Table 3). This information would be
valuable in counseling even for sporadic cases with POF, because
women with a heterozygous NR5A1 mutation are at potential risk
of passing it on to her 46,XY offspring.
In summary, we identified a single novel heterozygous NR5A1
mutation in a cohort of Chinese patients with 46,XX non-
syndromic POF. This mutation, located in non-domain region,
was transcriptionally impaired without a dominant negative effect.
Although NR5A1 perturbations appear to be a less common
explanation for POF, our identifying a causative mutation, in an
ethnic group (Han Chinese) different from that of other reports of
mutations, strengthens the case for NR5A1 playing a crucial role in
ovarian development and function in some women. Comprehen-
sive researches on signaling pathways associated to NR5A1 in
ovary are warranted to demonstrate its plausible causative roles in
human POF.
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